Jia Jenny Liu, Translational Lead of Early Phase Drug Development at The Kinghorn Cancer Centre, shared on LinkedIn:
“Abstract submissions are now open for the 2026 Clinical Oncology Society of Australia (COSA)
If you’re working to improve outcomes for people affected by cancer whether through research, clinical care, education, implementation, supportive care or health services we’d love to see your work showcased at COSAASM2026.
Abstract submissions close Friday 7 August 2026.
This year’s theme, ‘The Precision Generation: From Cancer Prevention to Personalised Care,’ reflects how cancer care is evolving beyond precision medicine alone. It’s about delivering the right care, to the right person, at the right time: through innovation, multidisciplinary collaboration, equity, and partnership with patients across the entire cancer journey.
We welcome submissions across a broad range of categories, including:
- Basic and Translational Research
- Clinical Research
- Education
- Epidemiology
- Health Services
- Supportive Care
- Precision Care (Conference Theme Stream)
- Trials in Progress
- Service Provision Posters
Whether you’re an early career researcher, clinician, nurse, allied health professional, scientist, consumer partner or established investigator, this is an opportunity to share your work with Australia’s multidisciplinary oncology community.
We look forward to seeing the breadth of outstanding work from across Australia and beyond, and to welcoming everyone to Sydney this November.”
Other articles about Clinical Oncology Society of Australia on OcnoDaily.